---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-045543"
form_type: "8-K"
ticker: "TPST"
cik: "0001544227"
company_name: "Tempest Therapeutics, Inc."
filed_at: "2026-02-11T23:59:59+00:00"
generated_at: "2026-05-16T03:17:58.857076+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Tempest Therapeutics files updated corporate presentation; no specific new data disclosed in filing.

## Summary
- Company posted February 2026 investor presentation on its website.
- Presentation title: 'Accelerating the Development of Advanced Therapies for Cancer Patients'.
- No financial or clinical trial results were included in the 8-K filing.
- Investors should refer to the full presentation on the company's website for details.

## SEC filing metadata
- accession: 0001193125-26-045543
- form_type: 8-K
- ticker: TPST
- cik: 0001544227
- company_name: Tempest Therapeutics, Inc.
- filed_at: 2026-02-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1544227/000119312526045543/0001193125-26-045543-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1544227/000119312526045543/d47566d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-045543
- JSON: https://secwatch.observer/filing/0001193125-26-045543.json
- Plain text: https://secwatch.observer/filing/0001193125-26-045543.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.